Ceftriaxone sodium powder for solution for injection

Country: Armenia

Bahasa: Inggeris

Sumber: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Bahan aktif:

ceftriaxone (ceftriaxone sodium)

Boleh didapati daripada:

Harbin Pharmaceutical Group Co.

Kod ATC:

J01DD04

INN (Nama Antarabangsa):

ceftriaxone (ceftriaxone sodium)

Dos:

1000mg

Borang farmaseutikal:

powder for solution for injection

Unit dalam pakej:

(10) glass vial

Jenis preskripsi:

Prescription

Status kebenaran:

Registered

Tarikh kebenaran:

2018-04-11

Ciri produk

哈药集团制药总厂
HARBIN PHARMACEUTICAL GROUP CO., LTD General Pharm. Factory
CEFTRIAXONE SODIUM FOR INJECTION 1.0 G
Table of Contents
1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
4.5 Interaction with other medicinal products and other forms of
interaction
4.6 Pregnancy and lactation
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
4.9 Overdose
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
5.2 Pharmacokinetic properties
5.3 Preclinical safety data
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
6.2 Incompatibilities
6.3 Shelf life
6.4 Special precautions for storage
6.5 Nature and contents of container
6.6 Special precautions for disposal and other handling
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT
LEGAL STATUS
哈药集团制药总厂
HARBIN PHARMACEUTICAL GROUP CO., LTD General Pharm. Factory
CEFTRIAXONE SODIUM FOR INJECTION 1.0 G
1. NAME OF THE MEDICINAL PRODUCT
Ceftriaxone sodium for injection 1g vials.
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1g vial contains 1g ceftriaxone as 1.19g hydrated disodium
ceftriaxone.
3. PHARMACEUTICAL FORM
Powder for solution for injection
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
Ceftriaxone is indicated for the treatment of the following infections
when
known or likely to be due to one or more susceptible micro-organisms
(see
section 5.1) and when parenteral therapy is required:
Pneumonia.
septicaemia.
Meningitis.
Bone, skin and soft tissue infections.
Infections in neutropenic patients.
Gonorrhoea.
Peri-operative prophylaxis of infections associated with surgery.
Treatment may be started before the results of susceptibility tests
are known.
Consideration should be given to off